DIANE WILDER, M.D.
Hematology & Oncology Physician · LITTLE ROCK, AR
Individual Active NPI 1619959525
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,427 | 222,865 | $14,682,281 | $5,236,085 | $4,180,563 |
| 2023 | 1,396 | 234,527 | $13,779,498 | $4,740,279 | $3,787,209 |
| 2022 | 1,514 | 305,007 | $13,018,216 | $3,988,468 | $3,195,514 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 22,800 | $55 | $43 |
| Q5125 | Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | 12,780 | $0 | $0 |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 12,750 | $0 | $0 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 11,700 | $0 | $0 |
| J9025 | Injection, azacitidine, 1 mg | 10,300 | $0 | $0 |
| J9299 | Injection, nivolumab, 1 mg | 8,700 | $31 | $25 |
| J0185 | Injection, aprepitant, 1 mg | 8,190 | $2 | $1 |
| J0897 | Injection, denosumab, 1 mg | 6,300 | $24 | $20 |
| J1437 | Injection, ferric derisomaltose, 10 mg | 6,300 | $20 | $16 |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 6,275 | $8 | $6 |
| J9267 | Injection, paclitaxel, 1 mg | 5,861 | $0 | $0 |
| J1453 | Injection, fosaprepitant, 1 mg | 5,400 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | E-3196 | AR |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Arkansas
- NPI 1578958401
- NPI 1609135797
- NPI 1871607770
- NPI 1407352040
- NPI 1033008321
- NPI 1417846726
- NPI 1902284326
- NPI 1497752638
See all Hematology & Oncology Physician providers in Arkansas →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.